Efficacy of a rapamycin analog (CCI-779) and IFN-? in tuberous sclerosis mouse models-Reference-Cited by-同舟云学术

Efficacy of a rapamycin analog (CCI-779) and IFN-? in tuberous sclerosis mouse models

Published:2005 Issue:3 Volume:42 Page:213-227
ISSN:1045-2257
Container-title:Genes, Chromosomes and Cancer
language:en
Short-container-title:Genes Chromosom. Cancer

Author:

Lee Laifong,Sudentas Paul,Donohue Brian,Asrican Kirsten,Worku Aelaf,Walker Victoria,Sun Yanping,Schmidt Karl,Albert Mitchell S.,El-Hashemite Nisreen,Lader Alan S.,Onda Hiroaki,Zhang Hongbing,Kwiatkowski David J.,Dabora Sandra L.

Publisher

Wiley

Subject

Cancer Research,Genetics

Reference44 articles.

1. Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis

2. Identification and characterization of the tuberous sclerosis gene on chromosome 16

3. Regulation of the TSC pathway by LKB1: evidence of a molecular link between tuberous sclerosis complex and Peutz-Jeghers syndrome

4. Mutational Analysis in a Cohort of 224 Tuberous Sclerosis Patients Indicates Increased Severity of TSC2, Compared with TSC1, Disease in Multiple Organs

5. Association between a High-Expressing Interferon-γ Allele and a Lower Frequency of Kidney Angiomyolipomas in TSC2 Patients

Cited by 151 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rapamycin and rapalogs for tuberous sclerosis complex;Cochrane Database of Systematic Reviews;2023-07-11

2. Upregulation of acid ceramidase contributes to tumor progression in tuberous sclerosis complex;JCI Insight;2023-05-08

3. mTORC1 upregulates B7-H3/CD276 to inhibit antitumor T cells and drive tumor immune evasion;Nature Communications;2023-03-03

4. Combination of Volasertib and Rapamycin Inhibits the Regrowth of TSC2-Deficient Tumors;2022-11-03

5. Dysregulation of Acid Ceramidase-mediated Sphingolipid Metabolism Contributes to Tumor Progression in Tuberous Sclerosis Complex;2022-09-26